Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Long noncoding RNA GSTM3TV2 upregulates LAT2 and OLR1 by competitively sponging let-7 to promote gemcitabine resistance in pancreatic cancer.

Xiong G, Liu C, Yang G, Feng M, Xu J, Zhao F, You L, Zhou L, Zheng L, Hu Y, Wang X, Zhang T, Zhao Y.

J Hematol Oncol. 2019 Sep 12;12(1):97. doi: 10.1186/s13045-019-0777-7.

2.

[The long coding RNA GSTM3TV2 acts an oncogene to promote chemoresistance in pancreatic cancer].

Xiong GB, Yang G, Feng MY, Zhao FY, Zheng LF, Zhang TP, Zhao YP.

Zhonghua Wai Ke Za Zhi. 2019 Sep 1;57(9):691-697. doi: 10.3760/cma.j.issn.0529-5815.2019.09.009. Chinese.

PMID:
31474062
3.

Integrative analysis of the lncRNA-associated ceRNA network reveals lncRNAs as potential prognostic biomarkers in human muscle-invasive bladder cancer.

Lyu L, Xiang W, Zhu JY, Huang T, Yuan JD, Zhang CH.

Cancer Manag Res. 2019 Jul 4;11:6061-6077. doi: 10.2147/CMAR.S207336. eCollection 2019.

4.

Construction and analysis of dysregulated lncRNA-associated ceRNA network identified novel lncRNA biomarkers for early diagnosis of human pancreatic cancer.

Zhou M, Diao Z, Yue X, Chen Y, Zhao H, Cheng L, Sun J.

Oncotarget. 2016 Aug 30;7(35):56383-56394. doi: 10.18632/oncotarget.10891.

5.

Long Noncoding RNA Expression Signatures of Colon Cancer Based on the ceRNA Network and Their Prognostic Value.

Cheng Y, Geng L, Wang K, Sun J, Xu W, Gong S, Zhu Y.

Dis Markers. 2019 Mar 11;2019:7636757. doi: 10.1155/2019/7636757. eCollection 2019.

7.

Comprehensive analysis of differentially expressed profiles of lncRNAs and circRNAs with associated co-expression and ceRNA networks in bladder carcinoma.

Huang M, Zhong Z, Lv M, Shu J, Tian Q, Chen J.

Oncotarget. 2016 Jul 26;7(30):47186-47200. doi: 10.18632/oncotarget.9706.

8.

LAT2 regulates glutamine-dependent mTOR activation to promote glycolysis and chemoresistance in pancreatic cancer.

Feng M, Xiong G, Cao Z, Yang G, Zheng S, Qiu J, You L, Zheng L, Zhang T, Zhao Y.

J Exp Clin Cancer Res. 2018 Nov 12;37(1):274. doi: 10.1186/s13046-018-0947-4.

9.

Integrative Analysis of Dysregulated lncRNA-Associated ceRNA Network Reveals Functional lncRNAs in Gastric Cancer.

Liu H, Zhang Z, Wu N, Guo H, Zhang H, Fan D, Nie Y, Liu Y.

Genes (Basel). 2018 Jun 18;9(6). pii: E303. doi: 10.3390/genes9060303.

10.

Integrated analysis of long noncoding RNA-associated competing endogenous RNA network in periodontitis.

Li S, Liu X, Li H, Pan H, Acharya A, Deng Y, Yu Y, Haak R, Schmidt J, Schmalz G, Ziebolz D.

J Periodontal Res. 2018 Aug;53(4):495-505. doi: 10.1111/jre.12539. Epub 2018 Mar 8.

PMID:
29516510
11.
12.
13.

Comprehensive Analysis of Differentially Expressed Profiles of lncRNAs/mRNAs and miRNAs with Associated ceRNA Networks in Triple-Negative Breast Cancer.

Yang R, Xing L, Wang M, Chi H, Zhang L, Chen J.

Cell Physiol Biochem. 2018;50(2):473-488. doi: 10.1159/000494162. Epub 2018 Oct 11.

14.

Comprehensive analysis of an lncRNA-miRNA-mRNA competing endogenous RNA network in pulpitis.

Lei F, Zhang H, Xie X.

PeerJ. 2019 Jun 17;7:e7135. doi: 10.7717/peerj.7135. eCollection 2019.

15.

Analysis of lncRNA-Associated ceRNA Network Reveals Potential lncRNA Biomarkers in Human Colon Adenocarcinoma.

Zhang Z, Qian W, Wang S, Ji D, Wang Q, Li J, Peng W, Gu J, Hu T, Ji B, Zhang Y, Wang S, Sun Y.

Cell Physiol Biochem. 2018;49(5):1778-1791. doi: 10.1159/000493623. Epub 2018 Sep 19.

16.

The topological key lncRNA H2k2 from the ceRNA network promotes mesangial cell proliferation in diabetic nephropathy via the miR-449a/b/Trim11/Mek signaling pathway.

Chen W, Peng R, Sun Y, Liu H, Zhang L, Peng H, Zhang Z.

FASEB J. 2019 Oct;33(10):11492-11506. doi: 10.1096/fj.201900522R. Epub 2019 Jul 23.

PMID:
31336052
17.

The long non-coding RNA HOTTIP promotes progression and gemcitabine resistance by regulating HOXA13 in pancreatic cancer.

Li Z, Zhao X, Zhou Y, Liu Y, Zhou Q, Ye H, Wang Y, Zeng J, Song Y, Gao W, Zheng S, Zhuang B, Chen H, Li W, Li H, Li H, Fu Z, Chen R.

J Transl Med. 2015 Mar 12;13:84. doi: 10.1186/s12967-015-0442-z.

18.

The construction and analysis of ceRNA networks in invasive breast cancer: a study based on The Cancer Genome Atlas.

Gao C, Li H, Zhuang J, Zhang H, Wang K, Yang J, Liu C, Liu L, Zhou C, Sun C.

Cancer Manag Res. 2018 Dec 17;11:1-11. doi: 10.2147/CMAR.S182521. eCollection 2019.

19.

Three-lncRNA signature is a potential prognostic biomarker for pancreatic adenocarcinoma.

Shi X, Zhao Y, He R, Zhou M, Pan S, Yu S, Xie Y, Li X, Wang M, Guo X, Qin R.

Oncotarget. 2018 Feb 8;9(36):24248-24259. doi: 10.18632/oncotarget.24443. eCollection 2018 May 11.

20.

Comprehensive analysis of a long noncoding RNA-associated competing endogenous RNA network in colorectal cancer.

Fan Q, Liu B.

Onco Targets Ther. 2018 May 1;11:2453-2466. doi: 10.2147/OTT.S158309. eCollection 2018.

Supplemental Content

Support Center